Sara Toftegaard Hjuler

813 total citations
18 papers, 482 citations indexed

About

Sara Toftegaard Hjuler is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Physiology. According to data from OpenAlex, Sara Toftegaard Hjuler has authored 18 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 8 papers in Epidemiology and 8 papers in Physiology. Recurrent topics in Sara Toftegaard Hjuler's work include Neuropeptides and Animal Physiology (8 papers), Adipose Tissue and Metabolism (6 papers) and Pancreatic function and diabetes (5 papers). Sara Toftegaard Hjuler is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Adipose Tissue and Metabolism (6 papers) and Pancreatic function and diabetes (5 papers). Sara Toftegaard Hjuler collaborates with scholars based in Denmark, United States and Australia. Sara Toftegaard Hjuler's co-authors include M.A. Karsdal, Kim Henriksen, Kim Vietz Andreassen, Lars Hellgren, Michael Feigh, Claus Christiansen, Patrick M. Sexton, Arthur Christopoulos, Sebastian G. B. Furness and Olivier Nosjean and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Sara Toftegaard Hjuler

18 papers receiving 475 citations

Peers

Countries citing papers authored by Sara Toftegaard Hjuler

Since Specialization

Citations

This map shows the geographic impact of Sara Toftegaard Hjuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Toftegaard Hjuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Toftegaard Hjuler more than expected).

Fields of papers citing papers by Sara Toftegaard Hjuler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Toftegaard Hjuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Toftegaard Hjuler. The network helps show where Sara Toftegaard Hjuler may publish in the future.

Co-authorship network of co-authors of Sara Toftegaard Hjuler

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Toftegaard Hjuler. A scholar is included among the top collaborators of Sara Toftegaard Hjuler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Toftegaard Hjuler. Sara Toftegaard Hjuler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period 2024 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Henning Hvid, Sara Toftegaard Hjuler, Pierre Bédossa, Dina Tiniakos, Ioannis Kamzolas, Lea Mørch Harder, Yaxin Xue, James W. Perfield, Rikke Kaae Kirk, Markus Latta, Lars Friis Mikkelsen, Henrik D. Pedersen, (unknown)	2
2	Standard procedures for blood withdrawal in conscious male rats induce stress and profoundly affect glucose tolerance and secretion of glucoregulatory hormones 2023 ·Molecular Metabolism ·(unknown), Helle Andersen, Christian Fledelius, Jens J. Holst, Sara Toftegaard Hjuler, Rune E. Kuhre	1
3	Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis 2020 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Samuel J. Daniels, Diana Julie Leeming, Sönke Detlefsen, (unknown), Sara Toftegaard Hjuler, Kim Henriksen, Peter Hein, Aleksander Krag, M.A. Karsdal, Mette Juul Nielsen, Sarah Brockbank, Simon Cruwys	4
4	Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue 2019 ·Biomedicine & Pharmacotherapy ·Samuel J. Daniels, Diana Julie Leeming, Sönke Detlefsen, (unknown), Sara Toftegaard Hjuler, Kim Henriksen, Peter Hein, M.A. Karsdal, Sarah Brockbank, Simon Cruwys	17
5	Assessment of liver fibrosis progression and regression by a serological collagen turnover profile 2018 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·M.A. Karsdal, Sara Toftegaard Hjuler, Yi Luo, Daniel Guldager Kring Rasmussen, Mette Juul Nielsen, Signe Holm Nielsen, Diana Julie Leeming, Zachary Goodman, Robert H. Arch, Keyur Patel, Detlef Schuppan	42
6	The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Sara Toftegaard Hjuler, (unknown), Kim Vietz Andreassen, M.A. Karsdal, Kim Henriksen	25
7	Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog 2017 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Kim Vietz Andreassen, Sara Toftegaard Hjuler, Lars Hellgren, M.A. Karsdal, Kim Henriksen	31
8	A novel dual amylin and calcitonin receptor agonist, KBP‐089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference 2017 ·British Journal of Pharmacology ·(unknown), Sara Toftegaard Hjuler, (unknown), Kim Vietz Andreassen, (unknown), Lars Hellgren, M.A. Karsdal, Kim Henriksen	52
9	Targeting a metabolic OA in vivo model by a novel dual amylin calcitonin receptor agonist, KBP-056 2016 ·Osteoarthritis and Cartilage ·(unknown), Sara Toftegaard Hjuler, (unknown), (unknown), M.A. Karsdal, Anne‐Christine Bay‐Jensen, Kim Henriksen	1
10	KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight 2016 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Kim Vietz Andreassen, Sara Toftegaard Hjuler, (unknown), M.A. Karsdal, Kim Henriksen	50
11	The dual amylin‐ and calcitonin‐receptor agonist KBP‐042 increases insulin sensitivity and induces weight loss in rats with obesity 2016 ·Obesity ·Sara Toftegaard Hjuler, (unknown), Kim Vietz Andreassen, (unknown), Lars Hellgren, M.A. Karsdal, Kim Henriksen	37
12	KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration 2015 ·European Journal of Pharmacology ·Sara Toftegaard Hjuler, Kim Vietz Andreassen, (unknown), M.A. Karsdal, Kim Henriksen	32
13	Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats 2014 ·European Journal of Pharmacology ·Michael Feigh, Sara Toftegaard Hjuler, Kim Vietz Andreassen, (unknown), (unknown), Jan Erik Henriksen, Henning Beck‐Nielsen, Claus Christiansen, M.A. Karsdal, Kim Henriksen	15
14	Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias 2014 ·PLoS ONE ·Kim Vietz Andreassen, Sara Toftegaard Hjuler, Sebastian G. B. Furness, Patrick M. Sexton, Arthur Christopoulos, Olivier Nosjean, M.A. Karsdal, Kim Henriksen	74
15	THU0205 Targeting the Bone-Driven Phenotype of OA by A Novel Calcitonin Analogue, Kbp088, Affecting Both Bone and Cartilage Turnover as Well as Metabolic Health 2014 ·Annals of the Rheumatic Diseases ·(unknown), Sara Toftegaard Hjuler, (unknown), M.A. Karsdal, Kim Henriksen, Anne‐Christine Bay‐Jensen	1
16	A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats 2014 ·American Journal of Physiology-Endocrinology and Metabolism ·Kim Vietz Andreassen, Michael Feigh, Sara Toftegaard Hjuler, (unknown), Jan Erik Henriksen, Henning Beck‐Nielsen, Claus Christiansen, M.A. Karsdal, Kim Henriksen	62
17	Oral salmon calcitonin protects against impaired fasting glycemia, glucose intolerance, and obesity induced by high-fat diet and ovariectomy in rats 2013 ·Menopause The Journal of The North American Menopause Society ·Michael Feigh, Kim Vietz Andreassen, Sara Toftegaard Hjuler, Rasmus Hjorth Nielsen, Claus Christiansen, Kim Henriksen, M.A. Karsdal	19
18	Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: How markers of β-cell loss may assist 2012 ·Journal of Translational Medicine ·A.V. Neutzsky-Wulff, Kim Vietz Andreassen, Sara Toftegaard Hjuler, Michael Feigh, Anne‐Christine Bay‐Jensen, Qinlong Zheng, Kim Henriksen, M.A. Karsdal	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact